Trial Profile
Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany Documentation of Vedolizumab Induction and Maintenance Therapy in Conjunction With Long-term Outcome and Predictors of Response
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2017
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Inflammatory bowel diseases
- Focus Adverse reactions
- Acronyms VEDOibdI
- 28 Dec 2017 New trial record